Skip to main content
Top
Published in: Community Mental Health Journal 5/2008

01-10-2008 | Original Paper

Hepatitis C Services and Individuals with Serious Mental Illness

Authors: Richard W. Goldberg, Puja Seth

Published in: Community Mental Health Journal | Issue 5/2008

Login to get access

Abstract

Although individuals with serious mental illness have been shown to be at increased risk for hepatitis C viral (HCV) infection, there is growing concern regarding limited dissemination of recommended HCV related services to this population. This paper presents rates of receipt of HCV prevention services among a cohort of seriously mentally ill adults and reports rates of recommended follow-up care among the subset who tested HCV positive in a pilot study. Previous HCV screening was low and indicated medical follow-up among those who tested positive was also limited. Results stress the need for increased screening and counseling and delivery of preventive and follow-up medical services.
Literature
go back to reference Connor, B. A., Blatter, M. M., Beran, J., Zou, B., & Trofa, A. F. (2007). Rapid and sustained immune response against Hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. Journal of Travel Medicine, 14, 9–15.PubMedCrossRef Connor, B. A., Blatter, M. M., Beran, J., Zou, B., & Trofa, A. F. (2007). Rapid and sustained immune response against Hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. Journal of Travel Medicine, 14, 9–15.PubMedCrossRef
go back to reference Czeschinksi, P. A., Binding, N., & Witting, U. (2000). Hepatitis A and hepatitis B vaccinations: Immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine, 18, 1074–1080.CrossRef Czeschinksi, P. A., Binding, N., & Witting, U. (2000). Hepatitis A and hepatitis B vaccinations: Immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine, 18, 1074–1080.CrossRef
go back to reference Department of Veteran Affairs. (2003). VA treatment recommendations: Patients with chronic hepatitis C. Federal Practitioner, 20(5), 1–32. Department of Veteran Affairs. (2003). VA treatment recommendations: Patients with chronic hepatitis C. Federal Practitioner, 20(5), 1–32.
go back to reference Dixon, L., Lyles, A., Smith, C., Hoch, J. S., Fahey, M., Postrado, L., et al. (2001). Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatric Services, 52, 786–792.PubMedCrossRef Dixon, L., Lyles, A., Smith, C., Hoch, J. S., Fahey, M., Postrado, L., et al. (2001). Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatric Services, 52, 786–792.PubMedCrossRef
go back to reference Dixon, L., Adler, D., Berlant, J., Dulit, R., Goldman, B., Hackman, A., Oslin, D., Siris, S., Sonis, W., & Valenstein, M. (2007). Best practices: Psychiatrists and primary caring: What are our boundaries of responsibility. Psychiatric Services, 58, 600–602.PubMedCrossRef Dixon, L., Adler, D., Berlant, J., Dulit, R., Goldman, B., Hackman, A., Oslin, D., Siris, S., Sonis, W., & Valenstein, M. (2007). Best practices: Psychiatrists and primary caring: What are our boundaries of responsibility. Psychiatric Services, 58, 600–602.PubMedCrossRef
go back to reference Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. I., & Krumholz, H. M. (2001). Quality and medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry, 58, 565–572.PubMedCrossRef Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. I., & Krumholz, H. M. (2001). Quality and medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry, 58, 565–572.PubMedCrossRef
go back to reference Essock, S. M., Dowden, S., Constantine, N. T., Katz, L., Swartz, M. S., Meado, K. G., et al. (2003). Blood-borne infections and persons with mental illness: Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Services, 54, 836–841.PubMedCrossRef Essock, S. M., Dowden, S., Constantine, N. T., Katz, L., Swartz, M. S., Meado, K. G., et al. (2003). Blood-borne infections and persons with mental illness: Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Services, 54, 836–841.PubMedCrossRef
go back to reference Goldberg, R. W. (2004). Hepatitis and HIV screening, education and treatment for adults with serious mental illness. General Hospital Psychiatry, 26(2), 167–168.PubMedCrossRef Goldberg, R. W. (2004). Hepatitis and HIV screening, education and treatment for adults with serious mental illness. General Hospital Psychiatry, 26(2), 167–168.PubMedCrossRef
go back to reference Goldberg, R. W., Himelhoch, S., Kreyenbuhl, J., Dickerson, F. B., Hackman, A., Fang, L. J., et al. (2005). Predictors of HIV and hepatitis testing and related service utilization among individuals with severe mental illness. Psychosomatics, 46, 573–577.PubMedCrossRef Goldberg, R. W., Himelhoch, S., Kreyenbuhl, J., Dickerson, F. B., Hackman, A., Fang, L. J., et al. (2005). Predictors of HIV and hepatitis testing and related service utilization among individuals with severe mental illness. Psychosomatics, 46, 573–577.PubMedCrossRef
go back to reference Ho, S. B., Nguyen, H., Tetrick, L. L., Opitz, G. A., Basara, M. L., & Dieperink, E. (2001). Influence of psychiatric diagnosis on interferon-alpha treatment for chronic hepatitis C in a veteran population. American Journal of Gastroenterology, 96, 157–164.PubMed Ho, S. B., Nguyen, H., Tetrick, L. L., Opitz, G. A., Basara, M. L., & Dieperink, E. (2001). Influence of psychiatric diagnosis on interferon-alpha treatment for chronic hepatitis C in a veteran population. American Journal of Gastroenterology, 96, 157–164.PubMed
go back to reference Kessler, R. C., Nelson, C. B., McGonagle, K. A., et al. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 31–77.CrossRef Kessler, R. C., Nelson, C. B., McGonagle, K. A., et al. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 31–77.CrossRef
go back to reference Klinkenberg, W. D., Caslyn, R. J., Morse, G. A., Yonker, R. D., McCudden, S., Ketema, F., et al. (2003). Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Comprehensive Psychiatry, 44(4), 293–302.PubMedCrossRef Klinkenberg, W. D., Caslyn, R. J., Morse, G. A., Yonker, R. D., McCudden, S., Ketema, F., et al. (2003). Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Comprehensive Psychiatry, 44(4), 293–302.PubMedCrossRef
go back to reference Koff, R. S. (2001). Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. Journal of Clinical Gastroenterology, 33, 2026.CrossRef Koff, R. S. (2001). Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. Journal of Clinical Gastroenterology, 33, 2026.CrossRef
go back to reference Lehman, A. L., Goldberg, R. W., Dixon, L. B., McNary, S., Postrado, L., et al. (2002). Improving employment outcomes for persons with severe mental illnesses. Archives of General Psychiatry, 59, 165–172.PubMedCrossRef Lehman, A. L., Goldberg, R. W., Dixon, L. B., McNary, S., Postrado, L., et al. (2002). Improving employment outcomes for persons with severe mental illnesses. Archives of General Psychiatry, 59, 165–172.PubMedCrossRef
go back to reference Meyer, J. M. (2003). Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: Results from Oregon State Hospital. Journal of Clinical Psychiatry, 64, 540–545.PubMedCrossRef Meyer, J. M. (2003). Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: Results from Oregon State Hospital. Journal of Clinical Psychiatry, 64, 540–545.PubMedCrossRef
go back to reference Mistler, L. A., Brunette, M. F., Marsh, B. J., Vidaver, R. M., Luckoor, R., & Rosenberg, S. D. (2006). Hepatitis C treatment for people with severe mental illness. Psychosomatics, 47, 93–107.PubMedCrossRef Mistler, L. A., Brunette, M. F., Marsh, B. J., Vidaver, R. M., Luckoor, R., & Rosenberg, S. D. (2006). Hepatitis C treatment for people with severe mental illness. Psychosomatics, 47, 93–107.PubMedCrossRef
go back to reference National Institutes of Health. (2002). National institutes of health consensus development conference statement: Management of hepatitis C: 2002. Hepatology, 36, S3–S20. National Institutes of Health. (2002). National institutes of health consensus development conference statement: Management of hepatitis C: 2002. Hepatology, 36, S3–S20.
go back to reference Osher, F. C., Goldberg, R. W., McNary, S. W., Swartz, M. S., Essock, S. M., Butterfield, M. I., et al. (2003). Blood-borne infections and persons with mental illness: Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric Services, 54, 842–847.PubMedCrossRef Osher, F. C., Goldberg, R. W., McNary, S. W., Swartz, M. S., Essock, S. M., Butterfield, M. I., et al. (2003). Blood-borne infections and persons with mental illness: Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric Services, 54, 842–847.PubMedCrossRef
go back to reference Reiss, G., & Keefe, E. B. (2004). Review article: Hepatitis vaccination in patients with chronic liver disease. Ailmentary Pharmacology and Therapeutics, 19, 715–727.CrossRef Reiss, G., & Keefe, E. B. (2004). Review article: Hepatitis vaccination in patients with chronic liver disease. Ailmentary Pharmacology and Therapeutics, 19, 715–727.CrossRef
go back to reference Rifai, M. A., Indest, D., Loftis, J., & Hauser, P. (2006). Psychiatric management of the hepatitis C patient. Current Treatment Options in Gastroenterology, 9, 508–519.PubMedCrossRef Rifai, M. A., Indest, D., Loftis, J., & Hauser, P. (2006). Psychiatric management of the hepatitis C patient. Current Treatment Options in Gastroenterology, 9, 508–519.PubMedCrossRef
go back to reference Rosenberg, S., Goodman, L., Osher, F., Swartz, M., Essock, S., Butterfield, N., Constantine, N., Wolford, G., & Salyers, M. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91, 31–37.PubMedCrossRef Rosenberg, S., Goodman, L., Osher, F., Swartz, M., Essock, S., Butterfield, N., Constantine, N., Wolford, G., & Salyers, M. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91, 31–37.PubMedCrossRef
go back to reference Rosenberg, S., Brunette, M., Oxman, T., Marsh, B., Dietrich, A., Mueser, K., et al. (2004). The STIRR model of best practices for blood-borne diseases among clients with serious mental illness. Psychiatric Services, 55(6), 660–664.PubMedCrossRef Rosenberg, S., Brunette, M., Oxman, T., Marsh, B., Dietrich, A., Mueser, K., et al. (2004). The STIRR model of best practices for blood-borne diseases among clients with serious mental illness. Psychiatric Services, 55(6), 660–664.PubMedCrossRef
go back to reference Schaefer, M., Schmidt, F., Fowaczny, C., Lorenz, R., Martin, G., Schindlbeck, N, et al. (2003). Adherene and mental side effects and during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology, 37, 443–451.PubMedCrossRef Schaefer, M., Schmidt, F., Fowaczny, C., Lorenz, R., Martin, G., Schindlbeck, N, et al. (2003). Adherene and mental side effects and during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology, 37, 443–451.PubMedCrossRef
go back to reference Sylvestre, D. L., Loftis, J. M., Hauser, P., Genser, S., Cesari, H., Borek, N., et al. (2004). Co-occurring hepatitis C, substance use, and psychiatric illness: Treatment issues and developing integrated models of care. Journal of Urban Health, 81(4), 719–734.PubMed Sylvestre, D. L., Loftis, J. M., Hauser, P., Genser, S., Cesari, H., Borek, N., et al. (2004). Co-occurring hepatitis C, substance use, and psychiatric illness: Treatment issues and developing integrated models of care. Journal of Urban Health, 81(4), 719–734.PubMed
go back to reference Yee, H. S., Currie, S. L., Darling, J. M., & Wright, T. L. (2006). Management and treatment of hepatitis C viral infection: Recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office. American Journal of Gastroenterology, 101, 2360–2378.PubMedCrossRef Yee, H. S., Currie, S. L., Darling, J. M., & Wright, T. L. (2006). Management and treatment of hepatitis C viral infection: Recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office. American Journal of Gastroenterology, 101, 2360–2378.PubMedCrossRef
Metadata
Title
Hepatitis C Services and Individuals with Serious Mental Illness
Authors
Richard W. Goldberg
Puja Seth
Publication date
01-10-2008
Publisher
Springer US
Published in
Community Mental Health Journal / Issue 5/2008
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-008-9140-0

Other articles of this Issue 5/2008

Community Mental Health Journal 5/2008 Go to the issue